[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,099
Citations 0
Comment & Response
March 5, 2014

Deaths and Cardiovascular Events in Men Receiving Testosterone

Author Affiliations
  • 1Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson
  • 2Department of Pharmacy Practice, University of Connecticut, Storrs
  • 3Division of Endocrinology, University of Mississippi Medical Center, Jackson
JAMA. 2014;311(9):963-964. doi:10.1001/jama.2014.386

To the Editor A retrospective cohort study by Dr Vigen and colleagues1 evaluated the association between testosterone therapy for men with total testosterone levels of less than 300 ng/dL and a composite outcome (all-cause mortality, myocardial infarction, and stroke). Flaws in the design and population of this study may have affected the validity of the conclusions drawn by Vigen et al.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×